AM Pharma
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
3
Funding Rounds
$302.8m
Money raised
Overview
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company AM Pharma has raised a total of $169.84m in funding over 3 rounds.
Key Insights:
- AM-Pharma , July 2019: $130m
- AM Pharma Series D round: $39.84m
- AM-Pharma funding round, July 2019: $133m
AM-Pharma , July 2019
$130m
AM Pharma Series D round
$39.84m
AM-Pharma funding round, July 2019
$133m
Industries
AM Pharma is active in the following industries: